HIV/AIDS Drug Development
Ginsenosides block ritonavir-induced vascular dysfunction of coronary arteries
Published in AIDS Weekly, July 18th, 2005
According to recent research published in the American Journal of Physiology - Heart and Circulatory Physiology, "Human immunodeficiency virus (HIV) protease inhibitor ritonavir (RTV) may induce vascular dysfunction through oxidative stress. Ginsenosides have been shown to have potential benefits on the cardiovascular system through diverse mechanisms, including antioxidative property."
"The objective of this study was to determine whether ginsenosides could prevent coronary arteries from RTV-induced dysfunction. Porcine coronary artery rings were incubated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-07-18)
More Articles from AIDS Weekly
- AIDS-Related Kaposi Sarcoma
Docetaxel rapidly effective in anthracycline-pretreated AIDS-related KS patients - HIV/AIDS Coinfection
HIV-specific cytolysis/increased IL-10 associated w/ S. mansoni coinfection - HIV/AIDS Drug Development
IL-4 antisense DNA inhibits pathogenic simian HIV replication in macaques - HIV/AIDS Prognostics
HIV-1-specific CD4 cell responses+IgG2 Ab predicts long-term nonprogression - Antimicrobial Drug Adherence
Pharmionics measures patient adherence to prescribed antimicrobial drug regimens - Aspergillosis
Scoring system developed to help predict risk of invasive aspergillosis - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
